ClinConnect ClinConnect Logo
Search / Trial NCT05924386

Marginal Bone Changes in Fixed All-on-Four Mandibular Prosthesis Using OT Bridge Attachment System

Launched by CAIRO UNIVERSITY · Jun 20, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

O Tbridge Attachment All On 4 Fixed Supported Implant Prosthesis Conventional Screw Retained Fixed Prosthesis

ClinConnect Summary

This clinical trial is studying two different methods of placing dental implants for patients who have lost all their teeth in their lower jaw (also known as an edentulous mandible). The trial compares a traditional method using multiunit abutments with a newer method that uses OT bridge attachments. Both methods involve placing four implants in specific positions to support a fixed set of teeth. Researchers will track changes in the bone around the implants and any issues that might arise with the dental prostheses over the course of a year.

To participate, patients need to be at least 40 years old, have good oral hygiene, and possess enough bone structure to support the implants. They should not have any serious health issues, such as uncontrolled diabetes or recent head or neck radiation. Participants can expect to have the implants placed and then wait about 8 to 12 weeks for healing before receiving their new teeth. Throughout the study, participants will have follow-up appointments to check on bone health and any complications with the prostheses. This trial is currently looking for volunteers who fit the criteria.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with completely edentulous patients
  • Aged 40 years or older.
  • Sufficient inter -arch space not less than 13 mm.
  • Good oral hygiene
  • Minimum bone height 10 mm and minimum bone diameter should be 6 mm
  • Exclusion Criteria:
  • General contraindications for oral surgery
  • Heavy smokers (greater than 20 cigarettes a
  • Local acute or chronic infections
  • Substance abuse (drugs or alcohol)
  • Patients with neuromuscular or psychiatric disorders.
  • Treatment with intravenous bisphosphonates
  • Irradiation of the neck or head area in the past 5 years
  • Diabetic patients (HbA1c\>7.5%)

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Cairo, , Egypt

Patients applied

0 patients applied

Trial Officials

nesma O elmosallamy

Principal Investigator

CAIRO UNIVERISTY

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported